Literature DB >> 33104025

The Relationship Between Anxiety and Incident Agitation in Alzheimer's Disease.

Kathy Y Liu1, Harry Costello1, Suzanne Reeves1, Robert Howard1.   

Abstract

BACKGROUND: Agitation in Alzheimer's disease (AD) has been hypothesized to be an expression of anxiety, but whether anxiety early in the course of dementia could be a risk factor for developing later agitation is unknown.
OBJECTIVE: We used the Alzheimer's Disease Neuroimaging Initiative (ADNI) database to examine the longitudinal relationship between anxiety and incident agitation in individuals with a diagnosis of AD at baseline or during follow-up.
METHODS: Longitudinal neuropsychiatric symptom data from AD individuals who were agitation-free at study baseline (N = 272) were analyzed using mixed effects regression models to test the longitudinal relationship between baseline and incident anxiety with incident agitation.
RESULTS: Anxiety at baseline was not associated with subsequent agitation, but there was a positive linear relationship between incident anxiety and agitation over the study duration. Baseline apathy and delusions were consistently associated with subsequent agitation and greater disease severity and illness duration also appeared to be risk factors for agitation.
CONCLUSION: Our findings support the concept that anxiety and agitation are likely to be distinct rather than equivalent constructs in mild-moderate AD. Future longitudinal cohort studies are needed to replicate these findings and further characterize potential risk factors for agitation, such as apathy and delusions.

Entities:  

Keywords:  Agitation; Alzheimer’s Disease Neuroimaging Initiative; Alzheimer’s disease; anxiety; apathy; delusions

Year:  2020        PMID: 33104025      PMCID: PMC7116438          DOI: 10.3233/JAD-200516

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  38 in total

Review 1.  Neuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits?

Authors:  Paul B Rosenberg; Milap A Nowrangi; Constantine G Lyketsos
Journal:  Mol Aspects Med       Date:  2015-06-03

2.  Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease. A longitudinal study.

Authors:  T Hope; J Keene; C G Fairburn; R Jacoby; R McShane
Journal:  Br J Psychiatry       Date:  1999-01       Impact factor: 9.319

3.  Risk factors for neuropsychiatric symptoms in dementia: the Cache County Study.

Authors:  M Steinberg; C Corcoran; J T Tschanz; C Huber; K Welsh-Bohmer; M C Norton; P Zandi; J C S Breitner; D C Steffens; C G Lyketsos
Journal:  Int J Geriatr Psychiatry       Date:  2006-09       Impact factor: 3.485

Review 4.  Apathy and noradrenaline: silent partners to mild cognitive impairment in Parkinson's disease?

Authors:  Leyla Loued-Khenissi; Kerstin Preuschoff
Journal:  Curr Opin Neurol       Date:  2015-08       Impact factor: 5.710

5.  Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia.

Authors:  Sytse U Zuidema; Els Derksen; Frans R J Verhey; Raymond T C M Koopmans
Journal:  Int J Geriatr Psychiatry       Date:  2007-07       Impact factor: 3.485

Review 6.  The relationship between anxiety disorders and age.

Authors:  C Krasucki; R Howard; A Mann
Journal:  Int J Geriatr Psychiatry       Date:  1998-02       Impact factor: 3.485

7.  Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease.

Authors:  Paula T Trzepacz; Peng Yu; Phani K Bhamidipati; Brian Willis; Tammy Forrester; Linda Tabas; Adam J Schwarz; Andrew J Saykin
Journal:  Alzheimers Dement       Date:  2012-12-17       Impact factor: 21.566

8.  Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease.

Authors:  Suzanne Reeves; Richard Brown; Robert Howard; Paul Grasby
Journal:  Neurology       Date:  2009-02-10       Impact factor: 9.910

9.  The individual course of neuropsychiatric symptoms in people with Alzheimer's and Lewy body dementia: 12-year longitudinal cohort study.

Authors:  Audun Osland Vik-Mo; Lasse Melvaer Giil; Miguel Germán Borda; Clive Ballard; Dag Aarsland
Journal:  Br J Psychiatry       Date:  2020-01       Impact factor: 9.319

10.  Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition.

Authors:  Jeffrey Cummings; Jacobo Mintzer; Henry Brodaty; Mary Sano; Sube Banerjee; D P Devanand; Serge Gauthier; Robert Howard; Krista Lanctôt; Constantine G Lyketsos; Elaine Peskind; Anton P Porsteinsson; Edgardo Reich; Cristina Sampaio; David Steffens; Marc Wortmann; Kate Zhong
Journal:  Int Psychogeriatr       Date:  2014-10-14       Impact factor: 3.878

View more
  2 in total

Review 1.  Emotional and Neuropsychiatric Disorders Associated with Alzheimer's Disease.

Authors:  Kenneth M Heilman; Stephen E Nadeau
Journal:  Neurotherapeutics       Date:  2022-01-10       Impact factor: 6.088

Review 2.  Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions.

Authors:  Claudia Carrarini; Mirella Russo; Fedele Dono; Filomena Barbone; Marianna G Rispoli; Laura Ferri; Martina Di Pietro; Anna Digiovanni; Paola Ajdinaj; Rino Speranza; Alberto Granzotto; Valerio Frazzini; Astrid Thomas; Andrea Pilotto; Alessandro Padovani; Marco Onofrj; Stefano L Sensi; Laura Bonanni
Journal:  Front Neurol       Date:  2021-04-16       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.